Larry St. Onge is President, Life Sciences and Healthcare, DHL. He is responsible for driving the growth and development of life sciences and healthcare business on a global scale and leads sector strategy along with commercial and solution development. Larry is focused on promoting patient-centric behavior across the business units.

In his articles, Larry shares the expert knowledge in new business models and trends, supply chain tracking and visibility, advanced data analytics, outsourced logistics management, temperature control and cold chain innovation, and more. These are crucial topics for the healthcare logistics industry, therefore enabling deep insight of these topics to the customers and colleagues is fundamental in order to evolve and deliver the best care to patients.

Preparing for the challenge of COVID-19 vaccine logistics

More than 250 potential COVID-19 vaccines are being developed currently worldwide. 10 billion – the estimated number of vaccine doses that would need to be delivered to all corners of the world within two years.

Necessity is the mother of invention: How healthcare needs are sparking logistics innovation

The global pandemic is causing a broad tranche of changes across all industries and some of these changes are extremely positive. In life sciences and healthcare, a welcome development has been a noticeable uptick in logistics innovation.

5 reasons why clinical trials need a customs control tower

Clinical trial shipments have priority at customs, but things can and do go wrong. Complex and fractured clinical trial brokerage, poor visibility of customs status and costs, delays resulting from document, license or permit irregularities, late clearance that adds storage expense and risks losing a trial, poor coordination between parties in the supply chain, and the destruction of late-arriving expired goods. These challenges will be familiar to clinical trial sponsors and contract research organizations (CROs) but there is a solution.